Tempus AI (NASDAQ:TEM) Shares Gap Up - Still a Buy?

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s share price gapped up before the market opened on Friday . The stock had previously closed at $35.29, but opened at $36.92. Tempus AI shares last traded at $37.10, with a volume of 1,362,172 shares.

Analysts Set New Price Targets

Several research firms recently commented on TEM. Guggenheim started coverage on Tempus AI in a research note on Monday, December 9th. They issued a "buy" rating and a $74.00 target price for the company. Loop Capital increased their target price on Tempus AI from $48.00 to $57.00 and gave the stock a "buy" rating in a research report on Tuesday, October 15th. Stifel Nicolaus downgraded Tempus AI from a "buy" rating to a "hold" rating and boosted their price target for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Piper Sandler restated a "neutral" rating and set a $70.00 price target (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Finally, Bank of America lifted their price objective on Tempus AI from $52.00 to $54.00 and gave the company a "neutral" rating in a research note on Friday, December 13th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, Tempus AI presently has a consensus rating of "Moderate Buy" and a consensus target price of $56.00.

Tempus AI Trading Down 0.5 %

The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The business has a 50 day simple moving average of $50.34.

Insider Activity

In other Tempus AI news, Director David R. Epstein sold 620 shares of the firm's stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $41.81, for a total transaction of $25,922.20. Following the completion of the transaction, the director now directly owns 27,894 shares of the company's stock, valued at $1,166,248.14. This trade represents a 2.17 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Bradley A. Keywell sold 395,800 shares of the business's stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $42.95, for a total transaction of $16,999,610.00. Following the completion of the sale, the insider now directly owns 16,164,449 shares of the company's stock, valued at $694,263,084.55. The trade was a 2.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 845,041 shares of company stock worth $35,125,473 over the last ninety days.

Hedge Funds Weigh In On Tempus AI

Hedge funds have recently bought and sold shares of the company. First Horizon Advisors Inc. bought a new stake in Tempus AI during the third quarter valued at $30,000. Sandia Investment Management LP acquired a new position in shares of Tempus AI in the 2nd quarter valued at about $136,000. Vestor Capital LLC bought a new stake in shares of Tempus AI during the 3rd quarter valued at about $153,000. Stifel Financial Corp acquired a new stake in Tempus AI during the third quarter worth about $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new position in Tempus AI in the third quarter worth about $258,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.